Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2007
10/10/2007CN100341886C Macrolide solvates
10/10/2007CN100341861C Process for extracting epigoitrin from isatis root and use thereof
10/10/2007CN100341855C 7-substituted-8-methoxy fluoroquinolone carboxylic derivatives, preparing process, preparation and use thereof
10/10/2007CN100341578C Anhydrous topical skin preparations
10/10/2007CN100341575C Water soluble dry compositions
10/10/2007CN100341574C Novel use of cell wall skeleton of red nocar-ray-fungus for treating liver diseases
10/10/2007CN100341573C Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/10/2007CN100341546C Pharmaceutical composition for resisting herpes simplex virus and its preparing process
10/10/2007CN100341537C Composition for treatment of B-type hepatitis and liver cirrhosis
10/10/2007CN100341536C Yinzhihuang dispersion tablet of oriental wormwood, cape jasmine and baicalin, and its preparing and detecting method
10/10/2007CN100341532C External use preparation for treating bliser tetter
10/10/2007CN100341517C Azithromycin dripping pill and its prepn
10/10/2007CN100341516C Hepatitis treating medicine and its preparation method
10/10/2007CN100341515C Film-coated tablet of glycyrrhizinic acid monopotassiium salt and method for preparing the same
10/10/2007CN100341513C Soft ointment for treating skin dermatomycosis
10/10/2007CN100341511C Itraconazole dripping pill and its prepn
10/10/2007CN100341510C 'Ennoxacin' micro-capsule, and its prepn. method
10/10/2007CN100341508C Soft capsule composition of compound cold-treating medicine
10/10/2007CN100341500C Emulsion containing dicaffeoyl quinic acid and its preparing method
10/10/2007CN100341493C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/10/2007CN100341487C 'Shuanghuang' antiphlogistic drop pill in use relieving inflammation and preparation method
10/10/2007CN100341428C Nutritional composition preventing bacterial overgrowth
10/10/2007CN100341408C Pyrithione biocides enhanced by silver, copper, or zinc ions
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279494 For therapy of bacterial infections; such as N-[((5S)-3-{3-fluoro-4-[exo-(1R,5S)-3-thiabicyclo[3.1.0]hex-6-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl]acetamide
10/09/2007US7279488 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions
10/09/2007US7279487 Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
10/09/2007US7279484 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
10/09/2007US7279483 Famciclovir monohydrate
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279465 Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases
10/09/2007US7279458 Glycopeptide group is covalently linked to a pyridinium moiety of a cephalosporin group; reacting a glycopeptide containing (c6.c6.c6.c6.c6.c10n2.c13n2o.c13n2o ring) with a cephalosporin or salt in presence of a diacid
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279175 Reduce restenosis coating on medical device
10/09/2007US7279169 A diphtheria toxoid, a tetanus toxoid, and a detoxified pertussis holotoxin; and a detoxified E. coli heat labile toxin that is is LT-K63 or LT-R72; is administered intranasally
10/09/2007US7279166 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
10/09/2007US7279164 Chimeric proteins that induce effects directed against viruses
10/09/2007CA2455012C Enteral compositions for the prevention and/or treatment of sepsis
10/09/2007CA2396174C Aerothricin analogs, their preparation and use
10/09/2007CA2156416C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
10/09/2007CA2145928C N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide, and a process for its preparation
10/04/2007WO2007112093A2 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
10/04/2007WO2007111940A2 Regimens for immunisation with meningococcal conjugates
10/04/2007WO2007111500A1 Immunization with transgenic mushrooms
10/04/2007WO2007111496A1 Improved carbohydrate recognition domains
10/04/2007WO2007111326A1 Whole cell vaccine suffering from no toxicity return even in prolonged storage and use thereof
10/04/2007WO2007111321A1 Method of analyzing sulfated polysaccharide or sulfated oligosaccharide, pharmaceutical composition and drug containing sulfated polysaccharide or sulfated oligosaccharide, method of producing the pharmaceutical composition and the drug and method of treating, diagnosing, symptom-relieving and preventing disease
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007111163A1 Nanocomposite particle
10/04/2007WO2007111023A1 Hydrate for medical purposes
10/04/2007WO2007110875A1 Antibiotic compositions of modified release and process of production thereof
10/04/2007WO2007110834A2 Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
10/04/2007WO2007110776A1 Storage of influenza vaccines without refrigeration
10/04/2007WO2007110500A1 Use of canthin-6-one and its analogues in the treatment of pathologies linked to mycobacteria
10/04/2007WO2007110171A1 Substituted n-benzyl-n-phenylbenzenesulphonamides for treating viral infections
10/04/2007WO2007092645A3 Novel hcv inhibitor combinations and methods
10/04/2007WO2007092616A3 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto
10/04/2007WO2007082734A3 Influenza vaccine
10/04/2007WO2007076005A3 Processes and intermediates useful for preparing integrase inhibitor compounds
10/04/2007WO2007073567A3 Compositions and methods of modulating the immune response
10/04/2007WO2007071658A3 Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
10/04/2007WO2007058568A3 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols
10/04/2007WO2007051468A3 Preparation of an antibiotic crystalline fusidic acid
10/04/2007WO2007038637A3 Human monoclonal antibodies to cd70
10/04/2007WO2007007352B1 A vaccine for staphylococcal infections
10/04/2007WO2006094810A3 Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
10/04/2007WO2005032462A3 Glucocerebroside treatment of disease
10/04/2007US20070232798 Process For The Synthesis Of 2'-O-Substituted Pyrimidines And Oligomeric Compounds Therefrom
10/04/2007US20070232639 Camptothecin Derivatives Conjugated in Position 20 with Integrin Antagonists
10/04/2007US20070232631 1-[4-(5-Bromopyrimidin-2-ylsulfanyl)phenyl]-3-(2-nitrobenzoyl)-urea; antiproliferative, water soluble compound with high bioavailability
10/04/2007US20070232623 Pyrazolopyrimidine and Pyrazolotriazine Derivatives and Pharmaceutical Compositions Containing Them
10/04/2007US20070232593 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO [1,2-a][1,4]BENZODIAZEPINES
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232557 Methods and compositions for inhibiting the function of polynucleotide sequences
10/04/2007US20070232549 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/04/2007US20070231830 Using competitive binding assays to identify peptide modulators for signal transduction
10/04/2007US20070231342 immunogenic compositions comprising combinations of biological molecules from Neisseria bacteria, particularly N. meningitidis and N. gonorrhoeae
10/04/2007US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/04/2007US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
10/04/2007US20070231266 Diagnosis of macrophage mediated disease
10/04/2007DE102006015573A1 Active substance fraction from Rheum species, obtained by extracting Rheum root samples with methanol, separating lipophilic material and condensing the fraction, useful for virus inactivation and disinfection
10/04/2007DE102006014390A1 Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung Associates of xanthates with cyclodextrins and their use
10/04/2007DE102006013957A1 Substituierte N-Benzyl-N-phenylbenzolsulfonamide Substituted N-benzyl-N-phenylbenzolsulfonamide
10/04/2007CA2646993A1 Regimens for immunisation with meningococcal conjugates
10/04/2007CA2646349A1 Storage of influenza vaccines without refrigeration
10/04/2007CA2645859A1 2'-fluoronucleoside phosphonates as antiviral agents
10/04/2007CA2645488A1 Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions
10/04/2007CA2644911A1 Antibiotic compositions of modified release and process of production thereof
10/04/2007CA2644621A1 Dsrna compositions and methods for treating hpv infection
10/03/2007EP1840214A1 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone
10/03/2007EP1840209A2 Adeno-associated virus vectors and use thereof
10/03/2007EP1840129A1 Imidazothiazole derivative and method for producing same
10/03/2007EP1840125A2 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
10/03/2007EP1839676A2 Erythropoietin derivates
10/03/2007EP1839672A2 Modified vaccinia virus Ankara for the vaccination of neonates
1 ... 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 ... 1798